Drug Recalls

Here you'll find every drug recall the FDA has issued, including prescription medications, over-the-counter drugs, compounded pharmacy products, and dietary supplements. We've been tracking these since 2006 and our database updates several times a day so you're always looking at current information.

Drugs get recalled for a number of reasons: contamination during manufacturing, incorrect potency or dosage, failed quality testing (like dissolution or stability tests), sterility problems in injectable products, or labeling and packaging errors that could cause someone to take the wrong dose. If you find a product on this list that you use, please follow the instructions provided by the FDA to take the necessary precautions.

17,529 total recalls
2 this month

Showing 781–800 of 17,529 recalls

March 4, 2025· Chattem Inc

Recalled Item: Unisom

The Issue: CGMP Deviations: Nitrosamine Drug Substance Related Issue impurity

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
February 28, 2025· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Carvedilol Tablets USP 25 mg

The Issue: CGMP Deviations; presence 'N-Nitroso Carvedilol I' Impurity above

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
February 28, 2025· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Carvedilol Tablets USP 12.5 mg

The Issue: CGMP Deviations; presence 'N-Nitroso Carvedilol I' Impurity above

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
February 28, 2025· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Carvedilol Tablets USP 3.125mg Tablets a.)100-count bottle (NDC 68462-162-01)

The Issue: CGMP Deviations; presence 'N-Nitroso Carvedilol I' Impurity above

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
February 28, 2025· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Carvedilol Tablets USP 6.25 mg

The Issue: CGMP Deviations; presence 'N-Nitroso Carvedilol I' Impurity above

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
February 28, 2025· Breckenridge Pharmaceutical, Inc.

Recalled Item: Duloxetine Delayed-Release Capsules

The Issue: CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
February 28, 2025· Breckenridge Pharmaceutical, Inc.

Recalled Item: Duloxetine Delayed-Release Capsules

The Issue: CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
February 28, 2025· Breckenridge Pharmaceutical, Inc.

Recalled Item: Duloxetine Delayed-Release Capsules

The Issue: CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
February 28, 2025· Sigan Industries Group Inc.

Recalled Item: Walgreens

The Issue: Chemical Contamination: Presence of benzene

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
February 27, 2025· Amgen, Inc.

Recalled Item: Neupogen (filgrastim) For Injection

The Issue: Stability data does not support expiry: the products

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
February 27, 2025· Amgen, Inc.

Recalled Item: Neupogen (filgrastim) For Injection

The Issue: Stability data does not support expiry: the products

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
February 25, 2025· A-S Medication Solutions LLC

Recalled Item: METFORMIN HYDROCHLORIDE EXTENDED- RELEASE 500MG

The Issue: Presence of Foreign Tablets/Capsules

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
February 25, 2025· MYLAN PHARMACEUTICALS INC

Recalled Item: Prasugrel Tablets

The Issue: Failed Quality Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
February 24, 2025· Imprimis NJOF, LLC

Recalled Item: Tropicamide - Proparacaine - Phenylephrine - Ketorolac Sterile Ophthalmic...

The Issue: Sub-Potent Drug: The stability batch showed a subpotent

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
February 24, 2025· Kowa Pharmaceuticals America

Recalled Item: Livalo (pitavatstatin) tablets

The Issue: Presence of foreign tablets/capsules

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskCompleted
Refund
February 24, 2025· Denison Pharmaceuticals, LLC

Recalled Item: Zapzyt

The Issue: Chemical Contamination: Presence of benzene

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
February 20, 2025· One Source Nutrition, Inc,

Recalled Item: Vitality

The Issue: Undeclared Sildenafil

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
February 20, 2025· Central Admixture Pharmacy Services, Inc.

Recalled Item: PHENYLephrine added to 0.9% sodium chloride

The Issue: Presence of Particulate Matter

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
February 18, 2025· Turbare Manufacturing

Recalled Item: Avastin 1.25 mg/0.05 mL in 0.25 mL Syringe

The Issue: Lack of Assurance of Sterility: due to a

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardCompleted
Refund
February 17, 2025· MEDLINE INDUSTRIES, LP - Northfield

Recalled Item: CURAD Alcohol Prep Pads

The Issue: Subpotent Drug

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund